Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism

NCT07137364 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT07137364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07137364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
Lead sponsor
Third Military Medical University
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2022
Completion date
April 30, 2026
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, primary aldosteronism